FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Naomi Hanson

Research Profile

Chemicals & Drugs

Physiology

Disorders

Concepts & Ideas

Procedures

Activities & Behaviors

Fasting

Co-author Network

Publications

TOP 3
Oluwabunmi A Tokede; Michael Y Tsai; Natalie A Weir; J Michael Gaziano; Robert J Glynn; Naomi Q Hanson; Andrew B Petrone; Luc Djoussé
Plasma phospholipid trans fatty acids and risk of heart failure.
Andrew B Petrone; Michael Y Tsai; Natalie Weir; J Michael Gaziano; Robert Glynn; Naomi Q Hanson; Luc Djoussé
Omega-6 fatty acids and risk of heart failure in the Physicians' Health Study.
Luc Djoussé; Naomi Q Hanson; Michael Y Tsai; Natalie L Weir; J Michael Gaziano
Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Naomi Hanson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Oluwabunmi A Tokede; Michael Y Tsai; Natalie A Weir; J Michael Gaziano; Robert J Glynn; Naomi Q Hanson; Andrew B Petrone; Luc Djoussé
Plasma phospholipid trans fatty acids and risk of heart failure.
The American journal of clinical nutrition 2013;97(4):698-705.
2013: Andrew B Petrone; Michael Y Tsai; Natalie Weir; J Michael Gaziano; Robert Glynn; Naomi Q Hanson; Luc Djoussé
Omega-6 fatty acids and risk of heart failure in the Physicians' Health Study.
The American journal of clinical nutrition 2013;97(1):66-71.
2012: Luc Djoussé; Naomi Q Hanson; Michael Y Tsai; Natalie L Weir; J Michael Gaziano
Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure.
Circulation. Heart failure 2012;5(6):703-9.
2012: Jemma B Wilk; J Michael Gaziano; Naomi Q Hanson; Michael Y Tsai; Luc Djoussé
Plasma and dietary omega-3 fatty acids, fish intake, and heart failure risk in the Physicians' Health Study.
The American journal of clinical nutrition 2012;96(4):882-8.
2011: Yan Dong; Brian T Steffen; Jing Cao; Alexander K Tsai; Jose Ordovas; Robert Straka; Xia Zhou; Edmond K Kabagambe; Naomi Q Hanson; Donna K Arnett; Michael Y Tsai
Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants.
Atherosclerosis 2011;214(2):422-5.
2010: Michael Y Tsai; Jose M Ordovas; Na Li; Robert J Straka; Naomi Q Hanson; Valerie L Arends; Donna K Arnett
Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network.
Molecular genetics and metabolism 2010;100(2):118-22.
2009: Alexander K Tsai; Na Li; Naomi Q Hanson; Michael Y Tsai; Weihong Tang
Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population.
Atherosclerosis 2009;207(2):487-91.
2009: Michael Y Tsai; Catherine Loria; Jing Cao; Y Kim; David S Siscovick; Pamela J Schreiner; Naomi Q Hanson
Polygenic association with total homocysteine in the post-folic acid fortification era: the CARDIA study.
Molecular genetics and metabolism 2009;98(1-2):181-6.
2009: Michael Y Tsai; Catherine Loria; Jing Cao; Yongin Kim; David Siscovick; Pamela J Schreiner; Naomi Q Hanson
Clinical utility of genotyping the 677C>T variant of methylenetetrahydrofolate reductase in humans is decreased in the post-folic acid fortification era.
The Journal of nutrition 2009;139(1):33-7.
2006: Jing Cao; Kerry A Schwichtenberg; Naomi Q Hanson; Michael Y Tsai
Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.
Clinical chemistry 2006;52(12):2265-72.
2005: Michael Y Tsai; Naomi Q Hanson; Robert J Straka; Tracy R Hoke; Jose Ordovas; James M Peacock; Valerie L Arends; Donna K Arnett
Effect of influenza vaccine on markers of inflammation and lipid profile.
The Journal of laboratory and clinical medicine 2005;145(6):323-7.
2005: Petter S Woll; Naomi Q Hanson; Valerie L Arends; Michael Y Tsai
Effect of two common polymorphisms in the ATP binding cassette transporter A1 gene on HDL-cholesterol concentration.
Clinical chemistry 2005;51(5):907-9.
2004: Michael Y Tsai; Angeliki Georgopoulos; James D Otvos; Jose Ordovas; Naomi Q Hanson; James M Peacock; Donna K Arnett
Comparison of ultracentrifugation and nuclear magnetic resonance spectroscopy in the quantification of triglyceride-rich lipoproteins after an oral fat load.
Clinical chemistry 2004;50(7):1201-4.
2004: Michael Y Tsai; Aras Omer; Hakan Sozen; Naomi Q Hanson; Petter S Woll; Valerie L Arends; Donald B Hunninghake; Arthur J Matas
Plasma homocysteine levels in living kidney donors before and after uninephrectomy.
The Journal of laboratory and clinical medicine 2004;143(6):340-3.
2003: Petter S Woll; Naomi Q Hanson; Michael Y Tsai
Absence of ABCA1 mutations in individuals with low serum HDL-cholesterol.
Clinical chemistry 2003;49(3):521-2.
2002: Cengiz Ermis; Micheal Y Tsai; Naomi Q Hanson; Nejat Akar; Aras Omer
Angiotensin I converting enzyme, angiotensin II type 1 receptor and angiotensinogen polymorphisms and early myocardial infarction in Turkish population.
Thrombosis and haemostasis 2002;88(4):693-4.
2002: Naomi Q Hanson; John H Eckfeldt; Kerry A Schwichtenberg; Aras Omer; Michael Y Tsai
Interlaboratory variation of plasma total homocysteine measurements: results of three successive homocysteine proficiency testing surveys.
Clinical chemistry 2002;48(9):1539-45.
2002: Aras Omer; Naomi Q Hanson; S M Bakanay; Michael Y Tsai; S Gulec
Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population.
Thrombosis and haemostasis 2002;87(2):347-9.
2002: Aras Omer; Naomi Q Hanson; Michael Y Tsai; Nigel S Key
Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism?
Thrombosis and haemostasis 2002;87(1):173-4.
2001: Naomi Q Hanson; Aras Omer; F Yang; Michael Y Tsai
C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease.
Clinical chemistry 2001;47(4):661-6.
2001: Michael Y Tsai; Naomi Q Hanson; R Bailey; G Rao; Donald B Hunninghake
Cystatin C is an independent predictor of fasting and post-methionine load total homocysteine concentrations among stable renal transplant recipients.
Clinical chemistry 2001;47(7):1263-8.
2000: F Yang; Naomi Q Hanson; Kerry A Schwichtenberg; Michael Y Tsai
Variable number tandem repeat in exon/intron border of the cystathionine beta-synthase gene: a single nucleotide substitution in the second repeat prevents multiple alternate splicing.
American journal of medical genetics 2000;95(4):385-90.
2000: Aras Omer; Naomi Q Hanson; F Yang; Michael Y Tsai
Influence of 699C-->T and 1080C-->T polymorphisms of the cystathionine beta-synthase gene on plasma homocysteine levels.
Clinical genetics 2000;58(6):455-9.
2000: Michael Y Tsai; MK Bignell; F Yang; B G Welge; K J Graham; Naomi Q Hanson
Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels.
Atherosclerosis 2000;149(1):131-7.
1999: Michael Y Tsai; F Yang; MK Bignell; Aras Omer; Naomi Q Hanson
Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine beta-synthase gene, and pyridoxal-5'-phosphate concentration.
Molecular genetics and metabolism 1999;67(4):352-6.
1999: Michael Y Tsai; B G Welge; Naomi Q Hanson; MK Bignell; J Vessey; Kerry A Schwichtenberg; F Yang; F E Bullemer; R Rasmussen; K J Graham
Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases.
Atherosclerosis 1999;143(1):163-70.
1998: Paula M Gallagher; Eileen Naughten; Naomi Q Hanson; Kerry A Schwichtenberg; MK Bignell; M Yuan; P Ward; Sufin Yap; A S Whitehead; Michael Y Tsai
Characterization of mutations in the cystathionine beta-synthase gene in Irish patients with homocystinuria.
Molecular genetics and metabolism 1998;65(4):298-302.
1997: Michael Y Tsai; P W Wong; UC Garg; Naomi Q Hanson; Kerry A Schwichtenberg
Identification of a splice site mutation in the cystathionine beta-synthase gene resulting in variable and novel splicing defects of pre-mRNA.
Biochemical and molecular medicine 1997;61(1):9-15.
1996: Michael Y Tsai; MK Bignell; Kerry A Schwichtenberg; Naomi Q Hanson
High prevalence of a mutation in the cystathionine beta-synthase gene.
American journal of human genetics 1996;59(6):1262-7.
1996: Michael Y Tsai; Naomi Q Hanson; MK Bignell; Kerry A Schwichtenberg
Simultaneous detection and screening of T833C and G919A mutations of the cystathionine beta-synthase gene by single-strand conformational polymorphism.
Clinical biochemistry 1996;29(5):473-7.
1996: Michael Y Tsai; U Garg; Nigel S Key; Naomi Q Hanson; A Suh; Kerry A Schwichtenberg
Molecular and biochemical approaches in the identification of heterozygotes for homocystinuria.
Atherosclerosis 1996;122(1):69-77.
1996: U C Garg; Naomi Q Hanson; Michael Y Tsai; J H Eckfeldt
Simple and rapid method for extraction of DNA from fresh and cryopreserved clotted human blood.
Clinical chemistry 1996;42(4):647-8.
1995: Michael Y Tsai; Naomi Q Hanson; Kerry A Schwichtenberg; U Garg
Amplification refractory mutation system to identify mutations in cystathionine beta-synthase deficiency.
Clinical chemistry 1995;41(12 Pt 1):1775-7.
1995: I Beheshti; Naomi Q Hanson; K R Copeland; U Garg; Michael Y Tsai
Single-strand conformational polymorphisms (SSCP): studies of the genetic polymorphisms of exon 4 of apolipoprotein C III.
Clinical biochemistry 1995;28(3):303-7.
1994: Michael Y Tsai; Naomi Q Hanson; K R Copeland; I Beheshti; U Garg
Determination of a T/G polymorphism at nucleotide 3206 of the apolipoprotein C III gene by amplification refractory mutation system.
Clinical chemistry 1994;40(12):2235-9.
1992: Anthony A Killeen; Naomi Q Hanson; R Eklund; C J Cairl; J H Eckfeldt
Prevalence of nonclassical congenital adrenal hyperplasia among women self-referred for electrolytic treatment of hirsutism.
American journal of medical genetics 1992;42(2):197-200.
1989: Naomi Q Hanson; E F Freier
Enzymic measurement of total bile acids adapted to the Cobas Fara centrifugal analyzer.
Clinical chemistry 1989;35(7):1538-9.
1987: Naomi Q Hanson; T S LeGeault; E F Freier
Immunonephelometry of apolipoprotein B with a centrifugal analyzer.
Clinical chemistry 1987;33(10):1882-4.
1986: Naomi Q Hanson; E F Freier
Nephelometric assay of apolipoprotein A-I with a centrifugal analyzer.
Clinical chemistry 1986;32(11):2090-3.
1985: Naomi Q Hanson; M L Anderson; E F Freier
Temperature control better than calibrators for precision in the microcolumn method for hemoglobin A1c.
Clinical chemistry 1985;31(2):339-40.
1983: Naomi Q Hanson; E F Freier
Enzyme inactivation in serum before determination of total bile acids.
Clinical chemistry 1983;29(6):1073-5.
1983: Naomi Q Hanson; E F Freier
Effect of protein on the determination of total bile acids in serum.
Clinical chemistry 1983;29(1):171-5.